Tian Dandan, Xu You, Wang Ying, Zhu Xirui, Huang Chun, Liu Min, Li Panlong, Li Xiangyong
Department of Hypertension, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.
Department of Clinical Laboratory, The Third Affifiliated Hospital, Southern Medical University, Guangzhou, China.
Front Cardiovasc Med. 2024 Jul 18;11:1306159. doi: 10.3389/fcvm.2024.1306159. eCollection 2024.
The risk factors of cardiovascular disease (CVD) in end-stage renal disease (ESRD) with hemodialysis remain not fully understood. In this study, we developed and validated a clinical-longitudinal model for predicting CVD in patients with hemodialysis, and employed Mendelian randomization to evaluate the causal 6study included 468 hemodialysis patients, and biochemical parameters were evaluated every three months. A generalized linear mixed (GLM) predictive model was applied to longitudinal clinical data. Calibration curves and area under the receiver operating characteristic curves (AUCs) were used to evaluate the performance of the model. Kaplan-Meier curves were applied to verify the effect of selected risk factors on the probability of CVD. Genome-wide association study (GWAS) data for CVD ( = 218,792,101,866 cases), end-stage renal disease (ESRD, = 16,405, 326 cases), diabetes ( = 202,046, 9,889 cases), creatinine ( = 7,810), and uric acid (UA, = 109,029) were obtained from the large-open GWAS project. The inverse-variance weighted MR was used as the main analysis to estimate the causal associations, and several sensitivity analyses were performed to assess pleiotropy and exclude variants with potential pleiotropic effects.
The AUCs of the GLM model was 0.93 (with accuracy rates of 93.9% and 93.1% for the training set and validation set, sensitivity of 0.95 and 0.94, specificity of 0.87 and 0.86). The final clinical-longitudinal model consisted of 5 risk factors, including age, diabetes, ipth, creatinine, and UA. Furthermore, the predicted CVD response also allowed for significant (< 0.05) discrimination between the Kaplan-Meier curves of each age, diabetes, ipth, and creatinine subclassification. MR analysis indicated that diabetes had a causal role in risk of CVD (=0.088, < 0.0001) and ESRD (=0.26, 0.007). In turn, ESRD was found to have a causal role in risk of diabetes (=0.027, = 0.013). Additionally, creatinine exhibited a causal role in the risk of ESRD (=4.42, = 0.01).
The results showed that old age, diabetes, and low level of ipth, creatinine, and UA were important risk factors for CVD in hemodialysis patients, and diabetes played an important bridging role in the link between ESRD and CVD.
终末期肾病(ESRD)行血液透析患者心血管疾病(CVD)的危险因素仍未完全明确。在本研究中,我们开发并验证了一种用于预测血液透析患者CVD的临床纵向模型,并采用孟德尔随机化方法评估因果关系。该研究纳入468例血液透析患者,每三个月评估一次生化参数。将广义线性混合(GLM)预测模型应用于纵向临床数据。采用校准曲线和受试者工作特征曲线下面积(AUC)评估模型性能。应用Kaplan-Meier曲线验证所选危险因素对CVD发生概率的影响。从大型开放全基因组关联研究(GWAS)项目中获取CVD(n = 218,792,101,866例)、终末期肾病(ESRD,n = 16,405,326例)、糖尿病(n = 202,046,9,889例)、肌酐(n = 7,810)和尿酸(UA,n = 109,029)的GWAS数据。采用逆方差加权孟德尔随机化作为主要分析方法来估计因果关联,并进行了多项敏感性分析以评估多效性并排除具有潜在多效性效应的变异。
GLM模型的AUC为0.93(训练集和验证集的准确率分别为93.9%和93.1%,敏感性分别为0.95和0.94,特异性分别为0.87和0.86)。最终的临床纵向模型由5个危险因素组成,包括年龄、糖尿病、全段甲状旁腺激素(iPTH)、肌酐和尿酸。此外,预测的CVD反应在各年龄、糖尿病、iPTH和肌酐亚分类的Kaplan-Meier曲线之间也存在显著(P < 0.05)差异。孟德尔随机化分析表明,糖尿病在CVD风险中具有因果作用(β = 0.088,P < 0.0001)和ESRD风险中具有因果作用(β = 0.26,P = 0.007)。反过来,发现ESRD在糖尿病风险中具有因果作用(β = 0.027,P = 0.013)。此外,肌酐在ESRD风险中具有因果作用(β = 4.42,P = 0.01)。
结果表明,高龄、糖尿病以及低水平的iPTH、肌酐和尿酸是血液透析患者CVD的重要危险因素,且糖尿病在ESRD与CVD的关联中起重要的桥梁作用。